Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.01,9]dodecane scaffold from the soft coral Sclerophytum humesi
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Phuong Vu Luu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Anthozoa, Sesquiterpenes. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Ministry of Education, National Science and Technology Council.
Abstract (Originalsprache)
Chemical investigation of the soft coral Sclerophytum humesi led to the discovery of (±)-norsclerohumin A (1), a pair of enantiomeric norsesquiterpenoids possessing an unprecedented oxatricyclo[7.2.1.01,9]dodecane scaffold with a rare C5-O-C8 intramolecular ether-bridge. Their structures were elucidated by comprehensive spectroscopic analysis, including NMR, HRESIMS, ECD, and DP4+ analysis. A plausible biosynthetic pathway is proposed to account for the formation of the unique ether-bridged oxatricyclic framework and the generation of the enantiomeric pair (±)-norsclerohumin A. In addition, the absolute configuration of sinunorcaryophyllenol (2) was fully determined for the first time. Mechanistic studies revealed pronounced stereoselective inhibition of acetylcholinesterase (AChE), in which (-)-1b was far more potent than its antipode (+)-1a, with IC50 values of 10.08 ± 0.48 μM and 149.8 ± 1.02 μM, respectively. Enzyme kinetics showed that (-)-1b is a mixed-type AChE inhibitor (Ki = 6.61 μM), binding both the free enzyme and enzyme-substrate complex. Molecular docking indicated that its ether-bridged oxatricyclic skeleton fits optimally in the AChE active site, stabilizing key interactions within both the catalytic and peripheral binding regions. Importantly, (-)-1b displayed selective AChE inhibition without detectable cytotoxicity toward normal cells (IC50 > 256 μM), underscoring its favorable safety profile. Furthermore, pharmacokinetic predictions and quantum chemical parameters further suggest favorable drug-like properties, including high gastrointestinal absorption, blood-brain barrier permeability, and low risk of P-glycoprotein/cytochrome P450 interactions. These findings highlight the oxatricyclo[7.2.1.01,9]dodecane scaffold as a promising lead for neurotherapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
- Department of Health Sciences, College of Natural Sciences, Can Tho University, Can Tho 94000, Vietnam.
- Department of Chemistry, College of Natural Sciences, Can Tho University, Can Tho 94000, Vietnam.
- Institute of Pharmaceutical Education and Research, Binh Duong University, Thu Dau Mot, Binh Duong 820000, Vietnam; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, T…
- Institute of Pharmaceutical Education and Research, Binh Duong University, Thu Dau Mot, Binh Duong 820000, Vietnam; Institute of Biological Chemistry, Academia Sinica, Taipei 115024, Taiwan.
- School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam; PhD Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University,…
Förderung
- Ministry of Education
- National Science and Technology Council
Zitieren
APA
Luu, P. V., Nguyen, C. Q., Ton-Nu, H. L., Phan, T. T., Huynh, Q. T., Pham, N. T., Le, H. G., Chen, L. Y., Chang, Y. C., Su, J. H., Peng, B. R., & Lai, K. H. (2026). Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.01,9]dodecane scaffold from the soft coral Sclerophytum humesi. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109652
Vancouver
Luu PV, Nguyen CQ, Ton-Nu HL, Phan TT, Huynh QT, Pham NT, et al. Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.01,9]dodecane scaffold from the soft coral Sclerophytum humesi. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109652
BibTeX
@article{Luu2026,
author = {Luu, Phuong Vu and Nguyen, Cuong-Quoc and Ton-Nu, Huong Lien and Phan, Thuy-Tien Thi and Huynh, Quoc-Dung Tran and Pham, Ngoc-Thac and Le, Huong-Giang and Chen, Lo-Yun and Chang, Yu-Chia and Su, Jui-Hsin and Peng, Bo-Rong and Lai, Kuei-Hung},
title = {Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.01,9]dodecane scaffold from the soft coral Sclerophytum humesi},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109652}
}
EUVIMED